For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

The EU CRISPR patent landscape: a complex battle In the patent field, CRISPR/Cas technology has sparked intense patent battles in Europe, with significant implications for innovation and market ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

It would also essentially consolidate most of the CRISPR/Cas9 patents, hopefully curbing future litigation and saving royalties. The market cap of Editas, however, would indicate that the value of ...

Broad Institute regarding invention of the groundbreaking CRISPR-Cas9 gene-editing technology ... and the threat of enforcement surrounding alleged improper patent listings, and was capped ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive internal research license. DUBLIN and CHESHIRE, United Kingdom ...

ERS Genomics Limited has announced a new license agreement with Cytosurge AG. This is a non-exclusive licensing agreement granting Cytosurge access to the ERS CRISPR/Cas9 patent portfolio. Never miss ...

This streamlined licensing option enables a broader spectrum of innovators to access CRISPR/Cas9 intellectual ... or technology-related patents. Interested organisations can verify their ...